Fujifilm Launches Systems Integration Platform Specifically Designed for Endoscopy Suites
FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic and enterprise imaging and integration solutions, today launched the industry’s first Systems Integration platform designed specifically to enhance image and data integration in endoscopy suites. Through specially designed hardware and software configurations, this scalable solution enables the multi-video and image routing and display capabilities that GI physicians need while performing advanced procedures.
“As innovators in endoscopic imaging, we understand that endoscopists require more video sources and more advanced image routing and display when performing intraoperative and therapeutic procedures,” says Devon Bream, MPH, FACHE, Global Vice President Endoscopy, General Manager Systems Integration, FUJIFILM Medical Systems U.S.A., Inc. “Our integration platform was designed for this level of image routing and display complexity in the OR. We realized that endoscopists would benefit greatly from leveraging our leading integration capabilities in their endoscopy suites, and we’re thrilled to deliver this solution.”
Fujifilm’s Systems Integration platform delivers a variety of differentiated benefits for endoscopy suites:
- Quad-Channel Recording – Physicians can record up to four separate sources with built-in image capture, enabling multi-image viewing on large wall-mounted flat panel displays. This allows physicians to see relevant imaging and data from a variety of sources (endoscopic ultrasound, endoscopy, fluoroscopy, patient vitals, MR/CT, in-room camera, etc.) in one centralized place.
- Teleconferencing/Broadcasting – Health teams can broadcast live endoscopic content to any networked destination, and communicate with key stakeholders and resources with Fujifilm’s integrated teleconference technology. A key advantage of this technology is that health teams can have virtual clinical support in the room with them.
- Interoperability and Image Recall – Fujifilm’s Intelligent Launch functionality enables seamless integration and in-room routing of picture archiving and communication system (PACS) images (i.e. MR, CT) during and while planning for endoscopy procedures. Images can be integrated into a health system’s endo-writing software so they can be accessed through the system’s electronic medical record system, enabling streamlined access for all clinicians involved in the patient’s care journey.
- Education – In-room cameras enable care teams to view side-by-side images along with procedural video for real-time comparison. This enables live procedures and courses to be recorded and reviewed for educational and training purposes- a process that would otherwise be too cumbersome to pursue.
The platform was recently installed at Brigham and Women’s Hospital and is currently being leveraged by clinicians along with the rest of Fujifilm’s endoscopic imaging portfolio, which was purchased and installed earlier this year.
“Having Fujifilm’s Systems Integration platform in our endoscopy suite has dramatically reduced our procedure times as we no longer have to unplug wires, change system inputs, and worry about images not routing or showing up on the right monitors,” says Dr. Chris Thompson, Director of Endoscopy, Brigham and Women’s Hospital. “We have seamless integration of all pertinent patient imaging and data without the hassle, and the time saved means patients spend less time under anesthesia, which is helping us to improve our care delivery.”
Learn more about Fujifilm’s Systems Integration solution for endoscopy suites by contacting Fujifilm via email at email@example.com, or online here.
People In This Post
Companies In This Post
- Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration Read more
- Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease Read more
- Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas Read more
- Quell Therapeutics Signs Agreement with AstraZeneca to Develop and Commercialize Engineered Treg Cell Therapies for Autoimmune Diseases Read more
- Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430 Read more